Logo

MRX

Marex Group plc Ordinary Shares

MRX

Marex Group plc Ordinary Shares • NASDAQ
$34.79 ▲ 0.03% (+0.01)
Market Cap $2.49 B
52w High $49.34
52w Low $27.91
Dividend Yield 0.59%
P/E 10.03
Volume 374.12K
Outstanding Shares 71.70M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q2-2025 $500.1M ▼ $93.4M ▼ $76.7M ▼ 15.337% ▲ $2.01 ▲ $109.4M ▼
Q4-2024 $2.155B ▲ $159.8M ▼ $115.1M ▲ 5.342% ▼ $1.54 ▲ $450.5M ▲
Q2-2024 $740M ▲ $291.1M ▼ $102.9M ▲ 13.905% ▲ $1.33 ▲ $406.6M ▲
Q4-2023 $720.7M ▼ $837.4M ▼ $50.5M ▼ 7.007% ▼ $0.72 ▼ $-118.7M ▼
Q2-2023 $1.161B $1.149B $90.8M 7.818% $1.28 $110.9M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q2-2025 $6.909B ▲ $31.188B ▲ $30.077B ▲ $1.111B ▲
Q4-2024 $5.214B ▲ $24.313B ▲ $23.336B ▲ $976.9M ▲
Q2-2024 $4.447B ▼ $17.189B ▼ $16.307B ▼ $882.3M ▲
Q4-2023 $4.733B ▲ $17.612B ▲ $16.836B ▲ $775.9M ▲
Q2-2023 $1.652B $16.304B $15.569B $735.2M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q2-2025 $149.2M ▲ $927.7M ▲ $-68.1M ▼ $-80.4M ▼ $3.375B ▲ $918.9M ▲
Q4-2024 $115.1M ▲ $711M ▲ $-24.6M ▼ $-33.4M ▼ $865.6M ▲ $704.6M ▲
Q2-2024 $102.9M ▲ $452.5M ▲ $-10.7M ▲ $-3.8M ▲ $438M ▼ $443.3M ▲
Q4-2023 $70.65M $367.5M $-48.8M $-36.4M $573.4M $361.45M
Q2-2023 $70.65M $367.5M $-48.8M $-36.4M $573.4M $361.45M

Five-Year Company Overview

Income Statement

Income Statement Marex’s income statement shows a business that has scaled up quickly while becoming more profitable. Revenue has grown strongly over the last five years, and operating profit has risen even faster, suggesting better efficiency and operating leverage. Net profit has increased steadily, and earnings per share have moved up as well, indicating that growth is actually reaching the bottom line. That said, the pattern in gross profit is a bit uneven, which hints at the inherently volatile nature of trading and capital markets activity. Overall, the trend is clearly upward, but results remain sensitive to market conditions and risk management quality.

Balance Sheet

Balance Sheet The balance sheet has expanded dramatically, with total assets and liabilities both rising sharply. This is typical for a capital markets firm that intermediates large client positions, but it also means the company runs with substantial leverage. Debt has grown meaningfully, while equity has increased more gradually, leaving a relatively thin capital cushion compared with the size of the balance sheet. Cash balances have improved over time but still represent only a small slice of total assets. In short, the balance sheet supports a much larger franchise than five years ago, but it depends heavily on borrowed funds and robust risk controls.

Cash Flow

Cash Flow Cash generation has improved from slightly negative to consistently positive, which is an encouraging sign of underlying business health. Operating cash flow has grown alongside earnings, and free cash flow is almost the same as operating cash flow, because the company spends very little on physical capital. This points to an asset-light, technology-driven model that can scale without huge reinvestment. The stronger cash profile gives Marex more flexibility to fund growth, absorb shocks, and pursue acquisitions, though its reliance on market activity means cash flows can still swing with trading cycles.

Competitive Edge

Competitive Edge Marex appears to have carved out a solid competitive position in global commodities and financial markets by combining multiple services under one roof: clearing, agency execution, market making, and hedging solutions. This diversification across products, asset classes, and regions helps smooth performance across different market environments and reduces dependence on any single revenue stream. Its role as a major clearer and liquidity provider creates network effects: more clients and volume attract even more activity. Strategic acquisitions have extended its reach, particularly in prime brokerage and outsourced trading. The main risks are intense competition from large banks and other non-bank brokers, regulatory complexity across jurisdictions, and the cyclical nature of trading volumes and volatility.

Innovation and R&D

Innovation and R&D Innovation at Marex is centered on building and owning its own technology rather than relying on third parties. Platforms like Neon (for trading and risk), Agile (for pricing and execution), and Nanolytics (for AI-driven analytics) give it control over client experience, speed, and product design. The firm is also pushing into higher-growth niches such as digital asset derivatives, structured products, and environmental markets, often as an early mover. These initiatives can deepen client relationships and open new fee pools, but they also come with execution and regulatory risks, especially in newer areas like crypto and carbon markets. Continuous investment to scale and upgrade its tech stack will be critical to maintaining this edge as rivals catch up.

Summary

Marex has transformed itself over the past five years into a larger, more profitable, and more diversified capital markets platform. Earnings and cash flow trends are positive, reflecting both growth and improved efficiency, although results remain inherently tied to volatile markets. The balance sheet is heavily geared, which is common in this industry but increases the importance of strong risk management and funding discipline. Technologically, Marex appears ahead of many peers, with in-house platforms and data capabilities that support scale and product innovation. Its focus on structured products, digital assets, and environmental markets, combined with active deal-making, provides multiple avenues for future growth. The overall picture is of a fast-growing, tech-enabled financial intermediary with meaningful opportunities, but also the usual leverage, regulatory, and market-cycle risks that come with operating in global trading and commodities markets.

NEWS

November 29, 2025 · 11:56 PM UTC

MRX DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Marex Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRX

Read more

November 29, 2025 · 10:30 PM UTC

MRX DEADLINE: ROSEN, A LONGSTANDING FIRM, Encourages Marex Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRX

Read more

November 29, 2025 · 8:10 AM UTC

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Marex Group

Read more

November 28, 2025 · 10:06 PM UTC

Marex Group Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Marex Group plc - MRX

Read more

November 28, 2025 · 12:00 PM UTC

MRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Marex Group plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Read more